FDA approves Apidra SoloSTAR - a prefilled disposable insulin pen.

Sanofi-aventis announced that the US Food and Drug Administration (FDA) approved Apidra SoloSTAR [insulin glulisine (rDNA origin) injection], a prefilled disposable pen containing rapid-acting insulin analog Apidra, which is indicated to improve glycemic control in adults and children (4 years and older) with Type 1 diabetes or adults with Type 2 diabetes. The approval of Apidra SoloSTAR follows the approval and launch of Lantus SoloSTAR [insulin glargine (rDNA origin) injection] in 2007. People living with diabetes who use both Lantus and Apidra to help manage their blood sugar will now have two pen delivery devices to make administration of their insulins convenient. …